The disparity in the compensation systems for individuals injured by vaccines in the United States. It highlights the significant differences between the National Vaccine Injury Compensation Program (VICP) and the Countermeasures Injury Compensation Program (CICP), particularly in the context of COVID-19 vaccines. The author, Dr. Robert W. Malone, emphasizes that injured individuals face challenges in obtaining compensation, and that the system is flawed and unjust.
1. Two Different Systems:
There are two compensation systems for vaccine injuries: VICP and CICP.
VICP compensates around 49% of claims while CICP compensates less than 1% of COVID-19 vaccine claims.
2. Lack of Knowledge:
Individuals receiving vaccines are often unaware of the two systems and their right to sue.
Patients should be informed during consent that they cannot sue in regular courts for vaccine-related injuries.
3. Historical Context:
The National Childhood Vaccine Injury Act of 1986 was created to protect vaccine manufacturers and ensure compensation for injured individuals.
In 2005, Congress passed the PREP Act, which granted significant immunity to pharmaceutical companies while limiting the compensation available to injured individuals.
4. Compensation Mechanisms:
VICP allows three years to file claims and provides lawyer fees and a review process.
CICP has a one-year claim period, does not allow for pain and suffering damages, and lacks a judicial review process for denials.
5. Compensation Disparities:
The overall compensation structure reflects a lack of support for injured individuals.
Injured persons often face ongoing financial burdens, medical expenses, and lost income, while manufacturers remain protected from litigation.
6. False Assumptions:
Advocates argue the rare occurrence of vaccine injuries, yet the system effectively ensures that most claims are denied.
Families dealing with severe vaccine-related injuries face difficulties in proving causation and lack access to legal support.
7. Policy Implications:
The imbalance in compensation systems raises moral and practical questions regarding government accountability.
It suggests that if the government restricts the right to sue, it has a duty to provide a fair compensation system.
8. Calls for Reform:
Proposals include extending claim filing periods, ensuring reasonable legal assistance, allowing appeals, and providing adequate compensation.
The compensation process should be transparent, rigorous, and humane, ensuring fair treatment for those injured.
9. Conclusion - A Fundamental Bargain:
The article concludes that if government policies impose vaccine mandates while shielding manufacturers from liability, there should be a robust and fair compensation mechanism for those affected.
Investing in proper compensation structures reflects the obligation of society to care for individuals who sustain injuries in the name of public health.
The author illustrates a critical divide between the compensation mechanisms for vaccine injuries under VICP and CICP, particularly in light of the COVID-19 pandemic. While the VICP offers a more supportive framework for claimants, the CICP systematically denies claims, leaving many without recourse. The historical evolution of vaccine legislation has eroded the initial promise of adequate compensation for injuries, and the article stresses the importance of reforming these systems to ensure justice for those harmed by vaccines. The narrative underscores a societal obligation to care for the injured as part of the public health framework.
No comments:
Post a Comment